Marketa Janatova

Assistanf Professor and researcher

Přírodovědecká Fakulta, Univerzita Karlova

Czech Republic

Research Interests

Explore related searches

Professors in Medical Science

Contact this professor

ORCID

Google Scholar

About

Marketa Janatova is an Assistant Professor and researcher at Univerzita Karlova 1. lékařská fakulta in the Czech Republic. Her research focuses on cancer genetics, particularly concerning germline predisposition to breast and ovarian cancer, as well as DNA repair mechanisms. Recent publications include studies on RNA isolation techniques, DNA double-strand break repair, and the evaluation of polygenic risk scores for cancer.

Marketa Janatova

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

Semi-automated RNA Isolation from Tempus Blood RNA Tubes Using the Magcore Plus II Instrument

A comprehensive study evaluating germline FANCG variants in predisposition to breast and ovarian cancer.

RAD18 directs DNA double-strand break repair by homologous recombination to post-replicative chromatin.

A deep intronic recurrent CHEK2 variant c.1009-118_1009-87delinsC affects pre-mRNA splicing and contributes to hereditary breast cancer predisposition

Population‐specific validation and comparison of the performance of 77‐ and 313‐variant polygenic risk scores for breast cancer risk prediction

Parallel DNA/RNA NGS Using an Identical Target Enrichment Panel in the Analysis of Hereditary Cancer Predisposition.

Germline pathogenic variants in the MRE11, RAD50, and NBN (MRN) genes in cancer predisposition: A systematic review and meta‐analysis

RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models.

A comprehensive analysis of germline predisposition to early-onset ovarian cancer.

The guidelines for clinical practice for carriers of germline mutations in hereditary breast, ovarian, prostate, and pancreatic cancer predisposition genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 (4.2024).

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk.

ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk

Germline multigene panel testing of patients with endometrial cancer.

Importance of Germline and Somatic Alterations in Human MRE11, RAD50, and NBN Genes Coding for MRN Complex

Polygenic risk score (PRS) and its potential for breast cancer risk stratification.

Classification of germline variants identified in cancer predisposition genetic testing – consensus of the CZECANCA consortium

Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?

Prevalence of germline pathogenic variants in cancer predisposing genes in Czech and Belgian pancreatic cancer patients

Re: ERCC3, a new ovarian cancer susceptibility gene?

Germline mutations in RAD51C and RAD51D and hereditary predisposition to ovarian cancer.

CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate.

Identification of Germline Mutations in Melanoma Patients with Early Onset, Double Primary Tumors, or Family Cancer History by NGS Analysis of 217 Genes.

Collaborators (14)

Kathleen Claes

Greet Wieme

Marco Montagna

FEI CHEN

Alexandra Martins

Mariarosaria Calvello

Matouš Palek

Banu K. Arun

Radka Štorchová

Bettina Blaumeiser

Lenka Foretova

Lidia Feliubadaló

Zdenek Kleibl

Marta Kalousova

How do I reach out?

Meet Kite AI